Vial Packaging Inner Outer Segmentation for Labeling Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing packaging for vials in clinical trials requires complete unpacking for ancillary labeling at the point of distribution, leading to inefficiencies and increased labeling costs, and does not allow for reduced labeling necessary for clinical trials or commercial use.
Innovation Solution
A package design featuring an inner portion folded into a shape to receive a vial, with an outer portion that removably receives the inner portion, allowing for reduced labeling and tamper evidence, while enabling access to the vial contents without removing it from the package.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If complete unpacking is performed for ancillary labeling at the point of distribution, then labeling requirements are met, but distribution efficiency decreases and costs increase
Solution Approach 1:
The packaging is divided into an inner portion (immediate container) and an outer portion (outer packaging), allowing the inner portion to be pre-labeled and sealed within the outer portion. This segmentation enables the inner portion to be prepared in advance with required labels, eliminating the need for complete unpacking at distribution points while maintaining labeling compliance.
Solution Approach 2:
The inner portion is pre-labeled and sealed with tamper-evident features before being placed in the outer portion. This preliminary action allows all necessary labeling to be completed in advance during manufacturing, so that at the point of distribution, only minimal unpacking is required, significantly improving distribution efficiency.
2Reliability
If complete unpacking is performed for ancillary labeling, then labeling requirements are met, but labeling costs increase
Solution Approach 1:
By separating the packaging into inner and outer portions, the system allows labeling to be applied only to the inner portion during its assembly, rather than requiring labeling of both inner and outer portions after unpacking. This reduces the total number of labeling operations required, thereby reducing labeling costs while maintaining compliance.
Solution Approach 2:
All necessary labeling is performed in advance on the inner portion during its assembly process, before the outer portion is applied. This preliminary labeling action eliminates the need for costly post-unpacking labeling operations at distribution points, significantly reducing overall labeling costs.
3Ease of operation
If the vial is accessible without removing it from the package, then ease of use is improved, but packaging complexity increases
Solution Approach 1:
The inner portion containing the vial is nested within the outer portion, with the inner portion designed to be removable as a complete unit. This nesting allows the vial to remain protected and secure within the packaging while still being easily accessible by simply removing the inner portion, avoiding the need for complex disassembly operations.
Solution Approach 2:
By segmenting the packaging into removable inner and outer portions, the system provides easy access to the vial through simple removal of the inner portion, while maintaining security and protection. This segmentation avoids the need for complex structural designs, achieving ease of operation with minimal added complexity.
4Ease of manufacture
If reduced labeling is implemented for clinical trials, then labeling costs decrease, but regulatory compliance becomes more challenging
Solution Approach 1:
The packaging is segmented into an inner portion that can be labeled with reduced or modified labeling for clinical trials, and an outer portion that provides the necessary regulatory information and tamper-evident features. This segmentation allows different labeling strategies to be applied to different portions, reducing overall labeling costs while maintaining regulatory compliance through the outer portion.
Solution Approach 2:
The inner portion is pre-labeled with reduced labeling appropriate for clinical trial requirements, and the outer portion is provided with necessary regulatory information. This preliminary preparation allows compliant packaging to be ready for distribution without requiring expensive post-unpacking labeling, balancing cost reduction with regulatory compliance.
Data Source
AI summary
A package for receiving a vial may include an inner portion folded into a first shape configured to receive the vial; an outer portion folded into a second shape configured to removably receive the first shape of the inner portion; and an identifying mark or label disposed on the inner portion and viewable when the inner portion is disposed within the outer portion. The inner portion may include top, bottom, and first and second side portions that define a first aperture configured to receive the vial, and a top flap securable to the top or first or second side portions so as to retain the vial within the first aperture. A second aperture defined in the top flap may permit access to contents of the vial without removing the vial from the inner portion, e.g., may have a diameter selected to permit the vial top to protrude therethrough.